Applications of liquid chromatography-mass spectrometry in doping control

Journal of Analytical Toxicology

Volumn 29, Issue 1, 2005, Pages 1-14

  Politi, Lucia ^a   Groppi, Angelo ^a   Polettini, Aldo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; ANABOLIC AGENT; ANTIESTROGEN; BENZOYLECGONINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOLDENONE; BUPRENORPHINE; CANNABINOID; CENTRAL STIMULANT AGENT; COCAINE; DEXTROMORAMIDE; DIAMORPHINE; DIURETIC AGENT; GLUCOCORTICOID; HYDROMORPHONE; ILLICIT DRUG; METHADONE; MORPHINE; NARCOTIC AGENT; OXYCODONE; OXYMORPHONE; PENTAZOCINE; PEPTIDE HORMONE; PETHIDINE; PROBENECID; STRYCHNINE; UNINDEXED DRUG;

CONFERENCE PAPER; DOPING; DRUG IDENTIFICATION; DRUG SCREENING; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDLINE; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; SOLID PHASE MICROEXTRACTION; SPORTS MEDICINE;

STRYCHNOS TOXIFERA;

EID: 12344300405     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/29.1.1     Document Type: Conference Paper

References (111)

1. H.H. Maurer. Liquid chromatography-mass spectrometry in forensic and clinical toxicology. J. Chromatogr. B 713: 3-25 (1998).
2. P. Marquet. Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Ther. Drug. Monit. 24: 255-276 (2002).
3. D.J. Borts and L.D. Bowers. Direct measurement of urinary testosterone and epitestosterone conjugates using high-performance liquid chromatography/tandem mass spectrometry. J. Mass Spectrom. 35: 50-61 (2000).
4. W. Naidong, W.Z. Shou, T. Addison, S. Maleki, and X. Jiang. Liquid chromatography/tandem mass spectrometric bioanalysis using normal-phase columns with aqueous/organic mobile phases - a novel approach of eliminating evaporation and reconstitution steps in 96-well SPE. Rapid Commun. Mass Spectrom. 16: 1965-1975 (2002).
5. National Center for Biotechnology Information, National Library of Medicine. PubMed, http://www4.ncbi.nlm.nih.gov/PubMed/, February 2004.
6. World Anti-Doping Agency, WADA Technical Document TD2003IDCR (2003), http://www.wada-ama.org/docs/web/standards_harmonization/code/criteria_1_2.pdf, August 2004.
7. World Anti-Doping Agency, The World Anti-Doping Code. The 2004 Prohibited List, International Standard. Update 25 November 2003, http://www.wada-ama.org/ docs/web/standards_harmonization/code/list_standard_2004.pdf, August 2004.
8. World Anti-Doping Agency, WADA Technical Document TD2004MRPL (2004), http://www.wada-ama.org/docs/web/standards_harmonization/code/perf_limits_2.pdf, August, 2004.
9. World Anti-Doping Agency, The 2004 Monitoring Program, http://www.wada-ama.org/docs/web/standards_harmonization/code/ list_monitoring_2004.pdf, August 2004.
10. J.F. Van Bocxlaer, K.M. Clauwaert, W.E. Lambert, D.L. Deforce, E.G. Van den Eeckhout, and A.P. De Leenheer. Liquid chromatography-mass spectrometry in forensic toxicology. Mass Spectrom. Rev. 19: 165-214 (2000).
11. H. Kataoka, H.L. Lord, and J. Pawliszyn. Simple and rapid determination of amphetamine, methamphetamine, and their methylenedioxy derivatives in urine by automated in-tube solid-phase microextraction coupled with liquid chromatography-electrospray ionization mass spectrometry. J. Anal. Toxicol. 24: 257-265 (2000).
12. H.K. Nordgren and O. Beck. Direct screening of urine for MDMA and MDA by liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 27: 15-19 (2003).
13. R. Dams, C.M. Murphy, W.E. Lambert, and M.A. Huestis. Urine drug testing for opioids, cocaine, and metabolites by direct injection liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 17: 1665-1670 (2003).
14. P.M. Jeanville, E.S. Estape, S.R. Needham, and M.J. Cole. Rapid confirmation/quantitation of cocaine and benzoylecgonine in urine utilizing high performance liquid chromatography and tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 11: 257-263 (2000).
15. P.M. Jeanville, E.S. Estape, I. Torres-Negron, and A. Marti. Rapid confirmation/quantitation of ecgonine methyl ester, benzoylecgonine, and cocaine in urine using on-line extraction coupled with fast HPLC and tandem mass spectrometry. J. Anal. Toxicol. 25: 69-75 (2001).
16. Food and Drug Administration of the United States, Guidance for Industry-Bioanalytical Method Validation, U.S. Department of Health and Human Services, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May 2001, http://www.fda.gov/cder/guidance/index.htm, August 2004.
17. K.A. Mortier, R. Dams, W.E. Lambert, E.A. De Letter, S. Van Calenbergh, and A.P. De Leenheer. Determination of paramethoxyamphetamine and other amphetamine-related designer drugs by liquid chromatography/sonic spray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 16: 865-870 (2002).
18. Olympic Movement Anti-Doping Code, Appendix A, Prohibited Classes of Substances and Prohibited Methods 2003, 1 January 2003, http://www.cces.ca/pdfs/ WADA-PUB-ProhibitedList2003-E.pdf, August, 2004.
19. M.J. Bogusz, R.D. Maier, M. Erkens, and S. Driessen. Determination of morphine and its 3- and 6-glucuronides, codeine, codeine-glucuronideand 6-monoacetylmorphine in body fluids by liquid chromatography atmospheric pressure chemical ionization mass spectrometry. J. Chromatogr. B 703: 115-127 (1997).
20. G. Schänzle, S. Li, G. Mikus, and U. Hofmann. Rapid, highly sensitive method for the determination of morphine and its metabolites in body fluids by liquid chromatography-mass spectrometry. J. Chromatogr. B 721: 55-65 (1999).
21. W. Naidong, J.W. Lee, X. Jiang, M. Wehling, J.D. Hulse, and P.P. Lin. Simultaneous assay of morphine, morphine-3-glucuronide and morphine-6- glucuronide in human plasma using normal-phase liquid chromatography-tandem mass spectrometry with a silica column and an aqueous organic mobile phase. J. Chromatogr. B 735: 255-269 (1999).
22. R. Kronstrand, T.G. Selden, and M. Josefsson. Analysis of buprenorphine, norbuprenorphine, and their glucuronides in urine by liquid chromatography-mass spectrometry. J. Anal. Toxicol. 27: 464-470 (2003).
23. H. Hoja, P. Marquet, B. Verneuil, H. Lotfi, J.L. Dupuy, and G. Lachatre. Determination of buprenorphine and norbuprenorphine in whole blood by liquid chromatography-mass spectrometry. J. Anal. Toxicol. 21: 160-165 (1997).
24. A. Polettini and M.A. Huestis. Simultaneous determination of buprenorphine, norbuprenorphine, and buprenorphine-glucuronide in plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 754: 447-459 (2001).
25. D.E. Moody, J.D. Laycock, A.C. Spanbauer, D.J. Crouch, R.L. Foltz, J.L. Josephs, L. Amass, and W.K. Bickel. Determination of buprenorphine in human plasma by gas chromatography-positive ion chemical ionization mass spectrometry and liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 21: 406-414 (1997).
26. B.K. Charles, J.E. Day, D.E. Rollins, D. Andrenyak, W. Ling, and D.G. Wilkins. Opiate recidivism in a drug-treatment program: comparison of hair and urine data. J. Anal. Toxicol. 27: 412-428 (2003).
27. M. Zheng, K.M. McErlane, and M.C. Ong. Hydromorphone metabolites: isolation and identification from pooled urine samples of a cancer patient. Xenobiotica 32: 427-439 (2002).
28. T. Imamura, K. Kudo, A. Namera, H. Tokunaga, M. Yashiki, N. Jitsufuchi, and T. Kojima. Liquid chromatography-fast atom bombardment mass spectrometry for detection and determination of pentazocine in human tissues. J. Chromatogr. B 731: 149-154 (1999).
29. T. Breindahl and K. Andreasen. Determination of 11-nor-delta9- tetrahydrocannabinol-9-carboxylic acid in urine using high-performance liquid chromatography and electrospray ionization mass spectrometry. J. Chromatogr. B 732: 155-164 (1999).
30. W. Weinmann, S. Vogt, R. Goerke, C. Muller, and A. Bromberger. Simultaneous determination of THC-COOH and THC-COOH-glucuronide in urine samples by LC/MS/MS. Forensic Sci. Int. 113: 381-387 (2000).
31. K. De Wasch, B. Le Bizec, H. De Brabander, F. Andre, and S. Impens. Consequence of boar edible tissue consumption on urinary profiles of nandrolone metabolites. II. Identification and quantification of 19-norsteroids responsible for 19-norandrosterone and 19-noretiocholanolone excretion in human urine. Rapid Commun. Mass Spectrom. 15: 1442-1447 (2001).
32. C. Ayotte, J.F. Levesque, M. Cleroux, A. Lajeunesse, D. Goudreault, and A. Fakirian. Sport nutritional supplements: quality and doping controls. Can. J. Appl. Physiol. 26: S120-129 (2001).
33. B. Le Bizec, I. Gaudin, F. Monteau, F. Andre, S. Impens, K. De Wasch, and H. De Brabander. Consequence of boar edible tissue consumption on urinary profiles of nandrolone metabolites. I. Mass spectrometric detection and quantification of 19-norandrosterone and 19-noretiocholanolone in human urine. Rapid Commun. Mass Spectrom. 14: 1058-1065 (2000).
34. B. Le Bizec, F. Monteau, I. Gaudin, and F. Andre. Evidence for the presence of endogenous 19-norandrosterone in human urine. J. Chromatogr. B 723: 157-172 (1999).
35. T. Kuuranne, T. Kotiaho, S. Pedersen-Bjergaard, K. Einar Rasmussen, A. Leinonen, S. Westwood, and R. Kostiainen. Feasibility of a liquid-phase microextraction sample clean-up and liquid chromatographic/mass spectrometric screening method for selected anabolic steroid glucuronides in biological samples. J. Mass Spectrom. 38: 16-26 (2003).
36. R. Draisci, L. Palleschi, E. Ferretti, L. Lucentini, and P. Cammarata. Quantitation of anabolic hormones and their metabolites in bovine serum and urine by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 870: 511-522 (2000).
37. J.Y. Kim, M.H. Choi, S.J. Kim, and B.C. Chung. Measurement of 19-nortestosterone and its esters in equine plasma by high-performance liquid chromatography with tandem mass spectrometry. Rapid Commun. Mass Spectrom. 14: 1835-1840 (2000).
38. R. Masse, C. Ayotte, H.G. Bi, and R. Dugal. Studies on anabolic steroids. III. Detection and characterization of stanozolol urinary metabolites in humans by gas chromatography-mass spectrometry. J. Chromatogr. 497: 17-37 (1989).
39. W. Schanzer, G. Opfermann, and M. Donike. Metabolism of stanozolol: identification and synthesis of urinary metabolites. J. Steroid Biochem. 36: 153-74 (1990).
40. M. Van De Wiele, K. De Wasch, J. Vercammen, D. Courtheyn, H. De Brabander, and S. Impens. Determination of 16beta-hydroxystanozolol in urine and faeces by liquid chromatography-multiple mass spectrometry. J. Chromatogr. A 904: 203-209 (2000).
41. H.F. De Brabander, K. De Wasch, L.A. van Ginkel, S.S. Sterk, M.H. Blokland, P. Delahaut, X. Taillieu, M. Dubois, C.J. Arts, M.J. van Baak, L.G. Gramberg, R. Schilt, E.O. van Bennekom, D. Courtheyn, J. Vercammen, and R.F. Witkamp. Multi-laboratory study of the analysis and kinetics of stanozolol and its metabolites in treated calves. Analyst 123: 2599-2604 (1998).
42. C. Van Poucke and C. Van Peteghem. Development and validation of a multi-analyte method for the detection of anabolic steroids in bovine urine with liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 772: 211-217 (2002).
43. A. Leinonen, T. Kuuranne, and R. Kostiainen. Liquid chromatography/mass spectrometry in anabolic steroid analysis-optimization and comparison of three ionization techniques: electrospray ionization, atmospheric pressure chemical ionization and atmospheric pressure photoionization. J. Mass Spectrom. 37: 693-698 (2002).
44. T.M. Williams, A.J. Kind, W.G. Hyde, and D.W. Hill. Characterization of urinary metabolites of testosterone, methyltestosterone, mibolerone and boldebone in greyhound dogs. J. Vet. Pharmacol. Ther. 23: 121-129 (2000).
45. S.M. Stanley, S. Kent, and J.P. Rodgers. Biotransformation of 17-alkyl steroids in the equine: high-performance liquid chromatography-mass spectrometric and gas chromatography-mass spectrometric analysis of fluoxymesterone metabolites in urine samples. J. Chromatogr. B 704: 119-128 (1997).
46. F. Buiarelli, G.P. Cartoni, F. Coccioli, A. De Rossi, and B. Neri. Determination of trenbolone and its metabolite in bovine fluids by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 784: 1-15 (2003).
47. Y. Kim, Y. Lee, M. Kim, Y.H. Yim, and W. Lee. Determination of the metabolites of gestrinone in human urine by high performance liquid chromatography, liquid chromatography/mass spectrometry and gas chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 14: 1717-1726 (2000).
48. L. Dehennin and A.M. Matsumoto. Long-term administration of testosterone enanthate to normal men: alterations of the urinary profile of androgen metabolites potentially useful for detection of testosterone misuse in sport. J. Steroid Biochem. Mol. Biol. 44: 179-189 (1993).
49. K.A. Bean and J.D. Henion. Direct determination of anabolic steroid conjugates in human urine by combined high-performance liquid chromatography and tandem mass spectrometry. J. Chromatogr. B 690: 65-75 (1997).
50. L. Dehennin. On the origin of physiologically high ratios of urinary testosterone to epitestosterone: consequences for reliable detection of testosterone administration by male athletes. J. Endocrinol. 142: 353-360 (1994).
51. L.D. Bowers and Sanaullah. Direct measurement of steroid sulfate and glucuronide conjugates with high-performance liquid chromatography-mass spectrometry. J. Chromatogr. B 687: 61-68 (1996).
52. C.H. Shackleton, H. Chuang, J. Kim, X. de la Torre, and J. Segura. Electrospray mass spectrometry of testosterone esters: potential for use in doping control. Steroids 62: 523-529 (1997).
53. A. Marwah, P. Marwah, and H. Lardy. High-performance liquid chromatographic analysis of dehydroepiandrosterone. J. Chromatogr. A 935: 279-296 (2001).
54. Q. Jia, M.F. Hong, Z.X. Pan, and S. Orndorff. Quantification of urine 17-ketosteroid sulfates and glucuronides by high-performance liquid chromatography-ion trap mass spectroscopy. J. Chromatogr. B 750: 81-91 (2001).
55. A. Polettini. Bioanalysis of beta 2-agonists by hyphenated chromatographic and mass spectrometric techniques. J. Chromatogr. B 687: 27-42 (1996).
56. F. Guan, C.E. Uboh, L.R. Soma, Y. Luo, R. Li, E.K. Birks, D. Teleis, J.A. Rudy, and D.S. Tsang. Quantification of clenbuterol in equine plasma, urine and tissue by liquid chromatography coupled on-line with quadrupole time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 16: 1642-1651 (2002).
57. E.A. Hogendoorn, P. van Zoonen, A. Polettini, and M. Montagna. Hyphenation of coupled-column liquid chromatography and thermospray tandem mass spectrometry for the rapid determination of beta 2-agonist residues in bovine urine using direct large-volume sample injection. Set-up of single-residue methods for clenbuterol and salbutamol. J. Mass Spectrom. 31: 418-426 (1996).
58. K. De Wasch, H. De Brabander, and D. Courtheyn. LC-MS-MS to detect and identify four beta-agonists and quantify clenbuterol in liver. Analyst 123: 2701-2705 (1998).
59. A.F. Lehner, J.D. Harkins, W. Karpiesiuk, W.E. Woods, N.E. Robinson, L. Dirikolu, M. Fisher, and T. Tobin. Clenbuterol in the horse: confirmation and quantitation of serum clenbuterol by LC-MS-MS after oral and intratracheal administration. J. Anal. Toxicol. 25: 280-287 (2001).
60. C. Crescenzi, S. Bayoudh, P.A. Cormack, T. Klein, and K. Ensing. Determination of clenbuterol in bovine liver by combining matrix solid-phase dispersion and molecular imprinted solid-phase extraction followed by liquid chromatography/electrospray ion trap multiple-stage mass spectrometry. Anal. Chem. 73: 2171-2177 (2001).
61. M. Kleinova, P. Zollner, H. Kahlbacher, W. Hochsteiner, and W. Lindner. Metabolic profiles of the mycotoxin zearalenone and of the growth promoter zeranol in urine, liver, and muscle of heifers. J. Agric. Food Chem. 50: 4769-4776 (2002).
62. M. Cazzola. A global strategy for prevention and detection of blood doping with erythropoietin and related drugs. Haematologica 85: 561-563 (2000).
63. S.M. Stanley and A. Poljak. Matrix-assisted laser-desorption time-of flight ionisation and high-performance liquid chromatography-electrospray ionisation mass spectral analyses of two glycosylated recombinant epoetins. J. Chromatogr. B 785: 205-218 (2003).
64. L.D. Bowers. Analytical advances in detection of performance-enhancing compounds. Clin. Chem. 43: 1299-1304 (1997).
65. L.D. Bowers and K. Fregien. HPLC/MS confirmation of peptide hormones in urine: an evaluation of limit of detection. In Recent advances in doping analysis; Proc. 11th Cologne Workshop on Dope Analysis. M. Donike, H. Geyer, A, Gotzmann, U. Mareck-Engelke, and S. Rauth, Eds. Verlag Sport and Buch Strausz, Cologne, Germany, 1994, pp 175-184.
66. S.L. Wu, H. Amato, R. Biringer, G. Choudhary, P. Shieh, and W.S. Hancock. Targeted proteomics of low-level proteins in human plasma by LC/MSn: using human growth hormone as a model system. J. Proteome Res. 1: 459-465 (2002).
67. S.S. de Kock, J.P. Rodgers, and B.C. Swanepoel. Growth hormone abuse in the horse: preliminary assessment of a mass spectrometric procedure for IGF-1 identification and quantitation. Rapid Commun. Mass Spectrom. 15: 1191-1197 (2001).
68. L.H. Gam, S.Y. Tham, and A. Latiff. Immunoaffinity extraction and tandem mass spectrometric analysis of human chorionic gonadotropin in doping analysis. J. Chromatogr. B 792: 187-196 (2003).
69. C. Liu and L.D. Bowers. Mass spectrometric characterization of the beta-subunit of human chorionic gonadotropin. J. Mass Spectrom. 32: 33-42 (1997).
70. C.L. Liu and L.D. Bowers. Immunoaffinity trapping of urinary human chorionic gonadotropin and its high-performance liquid chromatographic-mass spectrometric confirmation. J. Chromatogr. B 687: 213-220 (1996).
71. P.H. Sonksen. Insulin, growth hormone and sport. J. Endocrinol. 170: 13-25 (2001).
72. S.M. Darby, M.L. Miller, R.O. Allen, and M. LeBeau. A mass spectrometric method for quantitation of intact insulin in blood samples. J. Anal. Toxicol. 25: 8-14 (2001).
73. N.F. Visser, H. Lingeman, and H. Irth. On-line SPE-RP-LC for the determination of insulin derivatives in biological matrices. J. Pharm. Biomed. Anal. 32: 295-309 (2003).
74. D.R. Doerge, S. Bajic, and S. Lowes. Analysis of clenbuterol in human plasma using liquid chromatography/atmospheric-pressure chemical-ionization mass spectrometry. Rapid Commun. Mass Spectrom. 7: 462-464 (1993).
75. D.R. Doerge, S. Bajic, L.R. Blankenship, S.W. Preece, and M.I. Churchweel. Determination of beta-agonist residues in human plasma using liquid chromatography/atmospheric pressure chemical ionization mass spectrometry and tandem mass spectrometry. J. Mass Spectrom. 30: 911-916 (1995).
76. J.A. van Rhijn, M. O'Keeffe, H.H. Heskamp, and S. Collins. Rapid analysis of beta-agonists in urine by thermospray tandem mass spectrometry. J. Chromatogr. A 712: 67-73 (1995).
77. E.A. Hogendoorn, P. van Zoonen, A. Polettini, G. Marrubini Bouland, and M. Montagna. The potential of restricted access media columns as applied in coupled-column LC/LC-TSP/MS/MS for the high-speed determination of target compounds in serum. Application to the direct trace analysis of salbutamol and clenbuterol. Anal. Chem. 70: 1362-1368 (1998).
78. G. Biancotto, R. Angeletti, R.D. Piro, D. Favretto, and P. Traldi. Ion trap high-performance liquid chromatography/multiple mass spectrometry in the determination of beta-agonists in bovine urines. J. Mass Spectrom. 32: 781-784 (1997).
79. J. Cai and J. Henion. Quantitative multi-residue determination of beta-agonists in bovine urine using on-line immunoaffinity extraction-coupled column packed capillary liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 691: 357-370 (1997).
80. M. Thevis, G. Opfermann, and W. Schanzer. Liquid chromatography/ electrospray ionization tandem mass spectrometric screening and confirmation methods for beta2-agonists in human or equine urine. J. Mass Spectrom. 38: 1197-1206 (2003).
81. P. Van Eenoo, K. Deventer, and F.T. Delbeke. Quantitative detection of salmeterol after inhalation in equine urine by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 16: 1755-1759 (2002).
82. J.P. Antignac, P. Marchand, B. Le Bizec, and F. Andre. Identification of ractopamine residues in tissue and urine samples at ultra-trace level using liquid chromatography-positive electrospray tandem mass spectrometry. J. Chromatogr. B 774: 59-66 (2002).
83. K.B. Joyce, A.E. Jones, R.J. Scott, R.A. Biddlecombe, and S. Pleasance. Determination of the enantiomers of salbutamol and its 4-O-sulphate metabolites in biological matrices by chiral liquid chromatography tandem mass spectrometry. Rapid Commun. Mass Spectrom. 12: 1899-1910 (1998).
84. International Olympic Committee, Analytical criteria for reporting low concentrations of anabolic steroids, internal communication, IOC, Lausanne, Switzerland, 1998.
85. J. Zweigenbaum and J. Henion. Bioanalytical high-throughput selected reaction monitoring-LC/MS determination of selected estrogen receptor modulators in human plasma: 2000 samples/day. Anal. Chem. 72: 2446-2454 (2000).
86. J.M. Onorato, J.D. Henion, P.M. Lefebvre, and J.P. Kiplinger. Selected reaction monitoring LC-MS determination of idoxifene and its pyrrolidinone metabolite in human plasma using robotic high-throughput, sequential sample injection. Anal. Chem. 73: 119-125 (2001).
87. H. Zhang and J. Henion. Comparison between liquid chromatography-time of-flight mass spectrometry and selected reaction monitoring liquid chromatography-mass spectrometry for quantitative determination of idoxifene in human plasma. J. Chromatogr. B 757: 151-159 (2001).
88. C. Yang and J. Henion. Atmospheric pressure photoionization liquid chromatographic-mass spectrometric determination of idoxifene and its metabolites in human plasma. J. Chromatogr. A 970: 155-165 (2002).
89. S.W. Myung, H.K. Min, D.H. Kim, M. Kim, S. Cha, E.A. Yoo, and Y.H. Yim. Mass spectrometric analysis of cyclofenil and its metabolites in human urine. Rapid Commun. Mass Spectrom. 16: 761-767 (2002).
90. V. Cenacchi, S. Baratte, P. Cicioni, E. Frigerio, J. Long, and C. James. LC-MS-MS determination of exemestane in human plasma with heated nebulizer interface following solid-phase extraction in the 96 well plate format. J. Pharm. Biomed. Anal. 22: 451-460 (2000).
91. D. Thieme, J. Grosse, R. Lang, R.K. Mueller, and A. Wahl. Screening, confirmation and quantification of diuretics in urine for doping control analysis by high-performance liquid chromatography-atmospheric pressure ionisation tandem mass spectrometry. J. Chromatogr. B 757: 49-57 (2001).
92. K. Deventer, F.T. Delbeke, K. Roels, and P. Van Eenoo. Screening for 18 diuretics and probenecid in doping analysis by liquid chromatography-tandem mass spectrometry. Biomed. Chromatogr. 16: 529-535 (2002).
93. V. Sanz-Nebot, I. Toro, R. Serges, R. Ventura, J. Segura, and J. Barbosa. Determination and characterization of diuretics in human urine by liquid chromatography coupled to pneumatically assisted electrospray ionization mass spectrometry. J. Mass Spectrom. 36: 652-657 (2001).
94. S.D. Garbis, L. Hanley, and S. Kalita. Detection of thiazide-based diuretics in equine urine by liquid chromatography/mass spectrometry. J. AOAC Int. 81: 948-957 (1998).
95. Y. Kim, J. Hwang, M. Kim, and W. Lee. Determination of Tripamide in human urine by high-performance liquid chromatography and high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 17: 301-306 (2003).
96. A. Polettini, G. Marrubini Bouland, and M. Montagna. Development of a coupled-column liquid chromatographic-tandem mass spectrometric method for the direct determination of betamethasone in urine. J. Chromatogr. B 713: 339-352 (1998).
97. K. Deventer and F.T. Delbeke. Validation of a screening method for corticosteroids in doping analysis by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 17: 2107-2114 (2003).
98. K. Fluri, L. Rivier, A. Dienes-Nagy, C. You, A. Maitre, C. Schweizer, M. Saugy, and P. Mangin. Method for confirmation of synthetic corticosteroids in doping urine samples by liquid chromatography-electrospray ionisation mass spectrometry. J. Chromatogr. A 926: 87-95 (2001).
99. F. Bevalot, Y. Gaillard, M.A. Lhermitte, and G. Pepin. Analysis of corticosteroids in hair by liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B 740: 227-236 (2000).
100. J.P. Antignac, B. Le Bizec, F. Monteau, F. Poulain, and F. Andre. Multi-residue extraction-purification procedure for corticosteroids in biological samples for efficient control of their misuse in livestock production. J. Chromatogr. B 757: 11-19 (2001).
101. J.P. Antignac, B. Le Bizec, F. Monteau, and F. Andre. Study of natural and artificial corticosteroid phase II metabolites in bovine urine using HPLC-MS/MS. Steroids 67: 873-882 (2002).
102. P.M. Clarkson and H.S. Thompson. Drugs and sport. Research findings and limitations. Sports Med. 24: 366-384 (1997).
103. M. Thevis, G. Opfermann, and W. Schanzer. High speed determination of beta-receptor blocking agents in human urine by liquid chromatography/tandem mass spectrometry. Biomed. Chromatogr. 15: 393-402 (2001).
104. M. Gergov, J.N. Robson, E. Duchoslav, and I. Ojanpera. Automated liquid chromatographic/tandem mass spectrometric method for screening beta-blocking drugs in urine. J. Mass Spectrom. 35: 912-918 (2000).
105. H. Kataoka, S. Narimatsu, H.L. Lord, and J. Pawliszyn. Automated in-tube solid-phase microextraction coupled with liquid chromatography/electrospray ionization mass spectrometry for the determination of beta-blockers and metabolites in urine and serum samples. Anal. Chem. 71: 4237-4244 (1999).
106. N. Venisse, P. Marquet, E. Duchoslav, J.L. Dupuy, and G. Lachatre. A general unknown screening procedure for drugs and toxic compounds in serum using liquid chromatography-electrospray-single quadrupole mass spectrometry. J. Anal. Toxicol. 27: 7-14 (2003).
107. W. Weinmann, N. Lehmann, M. Renz, A. Wiedermann, and M. Svoboda. Screening for drugs in serum and in urine by LC/ESI/CID-MS and MS/MS with library searching. Probl. Forensic Sci. 42: 202-208 (2000).
108. M. Gergov, I. Ojanpera, and E. Vuori. Simultaneous screening for 238 drugs in blood by liquid chromatography-ion spray tandem mass spectrometry with multiple-reaction monitoring. J. Chromatogr. B 795: 41-53 (2003).
109. L. Rivier. Robustness evaluation for automatic identification of general unknown by reference ESI mass spectra comparison in LC-MS toxicological screening. Abstract of the 39th Meeting of The International Association of Forensic Toxicology (TIAFT), Prague, Czech Republic, August 26-30, 2001, L36.
110. M. Gergov, B. Boucher, I. Ojanpera, and E. Vuori. Toxicological screening of urine for drugs by liquid chromatography/time-of-flight mass spectrometry with automated target library search based on elemental formulas. Rapid Commun. Mass Spectrom. 15: 521-526 (2001).
111. A. Polettini. Use of LC-MS in forensic toxicology. 41st Meeting of The International Association of Forensic Toxicology (TIAFT), Melbourne, 16-20 November 2003, Abstract Book, Plenary 2.